Antibioprophylaxis in Prevention of Endophthalmitis in Intravitreal Injection: A Systematic Review and Meta-Analysis
Identifieur interne : 000615 ( Pmc/Corpus ); précédent : 000614; suivant : 000616Antibioprophylaxis in Prevention of Endophthalmitis in Intravitreal Injection: A Systematic Review and Meta-Analysis
Auteurs : Cédric Benoist D Zy ; Bruno Pereira ; Geraldine Naughton ; Frédéric Chiambaretta ; Frédéric DutheilSource :
- PLoS ONE [ 1932-6203 ] ; 2016.
Abstract
Despite endophthalmitis being the most feared complication, antibioprophylaxis remains controversial in intravitreal injections. Therefore, we conducted a systematic review and meta-analysis on the effects of antibioprophylaxis in intravitreal injections in the prevention of endophthalmitis. The PubMed, Cochrane Library, Embase and Science Direct databases were searched for studies comparing groups with and without antibiotics in intravitreal injection, with the use of the following keywords: "antibiotic*", "endophthalmitis" and “intravitreal injection*”. To be included, studies needed to specify number of participants and number of endophthalmitis within each group (with and without antibiotics). We conducted meta-analysis on the prevalence of clinical endophthalmitis including both culture-proven and culture negative samples. Nine studies were included. A total of 88 incidences of endophthalmitis were reported from 174,159 injections (0.051% i.e., one incidence of endophthalmitis for 1979 injections). Specifically, 59 incidences of endophthalmitis were reported from 113,530 injections in the group with antibiotics (0.052% or one incidence of endophthalmitis for 1924 injections) and 29 incidences of endophthalmitis from 60,633 injections in the group without antibiotics (0.048% or one endophthalmitis for 2091 injections). Our meta-analysis did not report a significant difference in the prevalence of clinical endophthalimitis between the two groups with and without topical antibiotics: the odds ratio of clinical endophthalimitis was 0.804 (CI95% 0.384–1.682, p = 0.56) for the antibiotic group compared with the group without antibiotics. In conclusion, we performed the first large meta-analysis demonstrating that antibioprophylaxis is not required in intravitreal injections. Strict rules of asepsis remain the only evidence-based prophylaxis of endophthalmitis. The results support initiatives to reduce the global threat of resistance to antibiotics.
Url:
DOI: 10.1371/journal.pone.0156431
PubMed: 27257676
PubMed Central: 4892688
Links to Exploration step
PMC:4892688Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Antibioprophylaxis in Prevention of Endophthalmitis in Intravitreal Injection: A Systematic Review and Meta-Analysis</title><author><name sortKey="Benoist D Zy, Cedric" sort="Benoist D Zy, Cedric" uniqKey="Benoist D Zy C" first="Cédric" last="Benoist D Zy">Cédric Benoist D Zy</name><affiliation><nlm:aff id="aff001"><addr-line>University Hospital of Clermont-Ferrand (CHU), Ophthalmology, Clermont-Ferrand, France</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff002"><addr-line>University Hospital of Clermont-Ferrand (CHU), Preventive and Occupational Medicine, Clermont-Ferrand, France</addr-line></nlm:aff></affiliation></author><author><name sortKey="Pereira, Bruno" sort="Pereira, Bruno" uniqKey="Pereira B" first="Bruno" last="Pereira">Bruno Pereira</name><affiliation><nlm:aff id="aff003"><addr-line>University Hospital of Clermont-Ferrand (CHU), Clinical Research Direction, Clermont-Ferrand, France</addr-line></nlm:aff></affiliation></author><author><name sortKey="Naughton, Geraldine" sort="Naughton, Geraldine" uniqKey="Naughton G" first="Geraldine" last="Naughton">Geraldine Naughton</name><affiliation><nlm:aff id="aff004"><addr-line>Australian Catholic University, Faculty of Health, Melbourne, Victoria, Australia</addr-line></nlm:aff></affiliation></author><author><name sortKey="Chiambaretta, Frederic" sort="Chiambaretta, Frederic" uniqKey="Chiambaretta F" first="Frédéric" last="Chiambaretta">Frédéric Chiambaretta</name><affiliation><nlm:aff id="aff001"><addr-line>University Hospital of Clermont-Ferrand (CHU), Ophthalmology, Clermont-Ferrand, France</addr-line></nlm:aff></affiliation></author><author><name sortKey="Dutheil, Frederic" sort="Dutheil, Frederic" uniqKey="Dutheil F" first="Frédéric" last="Dutheil">Frédéric Dutheil</name><affiliation><nlm:aff id="aff002"><addr-line>University Hospital of Clermont-Ferrand (CHU), Preventive and Occupational Medicine, Clermont-Ferrand, France</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff004"><addr-line>Australian Catholic University, Faculty of Health, Melbourne, Victoria, Australia</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff005"><addr-line>Clermont Auvergne University, Blaise Pascal University, Laboratory of Metabolic Adaptations to Exercise in Physiological and Pathological conditions EA3533, Clermont-Ferrand, France</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff006"><addr-line>Research Centre in Human Nutrition (CRNH) Auvergne, Clermont-Ferrand, France</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff007"><addr-line>CNRS, UMR 6024, Physiological and Psychosocial Stress, LAPSCO, University Clermont Auvergne, Clermont-Ferrand, France</addr-line></nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">27257676</idno><idno type="pmc">4892688</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892688</idno><idno type="RBID">PMC:4892688</idno><idno type="doi">10.1371/journal.pone.0156431</idno><date when="2016">2016</date><idno type="wicri:Area/Pmc/Corpus">000615</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000615</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Antibioprophylaxis in Prevention of Endophthalmitis in Intravitreal Injection: A Systematic Review and Meta-Analysis</title><author><name sortKey="Benoist D Zy, Cedric" sort="Benoist D Zy, Cedric" uniqKey="Benoist D Zy C" first="Cédric" last="Benoist D Zy">Cédric Benoist D Zy</name><affiliation><nlm:aff id="aff001"><addr-line>University Hospital of Clermont-Ferrand (CHU), Ophthalmology, Clermont-Ferrand, France</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff002"><addr-line>University Hospital of Clermont-Ferrand (CHU), Preventive and Occupational Medicine, Clermont-Ferrand, France</addr-line></nlm:aff></affiliation></author><author><name sortKey="Pereira, Bruno" sort="Pereira, Bruno" uniqKey="Pereira B" first="Bruno" last="Pereira">Bruno Pereira</name><affiliation><nlm:aff id="aff003"><addr-line>University Hospital of Clermont-Ferrand (CHU), Clinical Research Direction, Clermont-Ferrand, France</addr-line></nlm:aff></affiliation></author><author><name sortKey="Naughton, Geraldine" sort="Naughton, Geraldine" uniqKey="Naughton G" first="Geraldine" last="Naughton">Geraldine Naughton</name><affiliation><nlm:aff id="aff004"><addr-line>Australian Catholic University, Faculty of Health, Melbourne, Victoria, Australia</addr-line></nlm:aff></affiliation></author><author><name sortKey="Chiambaretta, Frederic" sort="Chiambaretta, Frederic" uniqKey="Chiambaretta F" first="Frédéric" last="Chiambaretta">Frédéric Chiambaretta</name><affiliation><nlm:aff id="aff001"><addr-line>University Hospital of Clermont-Ferrand (CHU), Ophthalmology, Clermont-Ferrand, France</addr-line></nlm:aff></affiliation></author><author><name sortKey="Dutheil, Frederic" sort="Dutheil, Frederic" uniqKey="Dutheil F" first="Frédéric" last="Dutheil">Frédéric Dutheil</name><affiliation><nlm:aff id="aff002"><addr-line>University Hospital of Clermont-Ferrand (CHU), Preventive and Occupational Medicine, Clermont-Ferrand, France</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff004"><addr-line>Australian Catholic University, Faculty of Health, Melbourne, Victoria, Australia</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff005"><addr-line>Clermont Auvergne University, Blaise Pascal University, Laboratory of Metabolic Adaptations to Exercise in Physiological and Pathological conditions EA3533, Clermont-Ferrand, France</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff006"><addr-line>Research Centre in Human Nutrition (CRNH) Auvergne, Clermont-Ferrand, France</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff007"><addr-line>CNRS, UMR 6024, Physiological and Psychosocial Stress, LAPSCO, University Clermont Auvergne, Clermont-Ferrand, France</addr-line></nlm:aff></affiliation></author></analytic><series><title level="j">PLoS ONE</title><idno type="eISSN">1932-6203</idno><imprint><date when="2016">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Despite endophthalmitis being the most feared complication, antibioprophylaxis remains controversial in intravitreal injections. Therefore, we conducted a systematic review and meta-analysis on the effects of antibioprophylaxis in intravitreal injections in the prevention of endophthalmitis. The PubMed, Cochrane Library, Embase and Science Direct databases were searched for studies comparing groups with and without antibiotics in intravitreal injection, with the use of the following keywords: "antibiotic*", "endophthalmitis" and “intravitreal injection*”. To be included, studies needed to specify number of participants and number of endophthalmitis within each group (with and without antibiotics). We conducted meta-analysis on the prevalence of clinical endophthalmitis including both culture-proven and culture negative samples. Nine studies were included. A total of 88 incidences of endophthalmitis were reported from 174,159 injections (0.051% i.e., one incidence of endophthalmitis for 1979 injections). Specifically, 59 incidences of endophthalmitis were reported from 113,530 injections in the group with antibiotics (0.052% or one incidence of endophthalmitis for 1924 injections) and 29 incidences of endophthalmitis from 60,633 injections in the group without antibiotics (0.048% or one endophthalmitis for 2091 injections). Our meta-analysis did not report a significant difference in the prevalence of clinical endophthalimitis between the two groups with and without topical antibiotics: the odds ratio of clinical endophthalimitis was 0.804 (CI95% 0.384–1.682, p = 0.56) for the antibiotic group compared with the group without antibiotics. In conclusion, we performed the first large meta-analysis demonstrating that antibioprophylaxis is not required in intravitreal injections. Strict rules of asepsis remain the only evidence-based prophylaxis of endophthalmitis. The results support initiatives to reduce the global threat of resistance to antibiotics.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Avery, Rl" uniqKey="Avery R">RL Avery</name></author><author><name sortKey="Bakri, Sj" uniqKey="Bakri S">SJ Bakri</name></author><author><name sortKey="Blumenkranz, Ms" uniqKey="Blumenkranz M">MS Blumenkranz</name></author><author><name sortKey="Brucker, Aj" uniqKey="Brucker A">AJ Brucker</name></author><author><name sortKey="Cunningham, Et" uniqKey="Cunningham E">ET Cunningham</name></author><author><name sortKey="D Amico, Dj" uniqKey="D Amico D">DJ D'Amico</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wykoff, Cc" uniqKey="Wykoff C">CC Wykoff</name></author><author><name sortKey="Flynn, Hw" uniqKey="Flynn H">HW Flynn</name></author><author><name sortKey="Rosenfeld, Pj" uniqKey="Rosenfeld P">PJ Rosenfeld</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="De Caro, Jj" uniqKey="De Caro J">JJ de Caro</name></author><author><name sortKey="Ta, Cn" uniqKey="Ta C">CN Ta</name></author><author><name sortKey="Ho, Hk" uniqKey="Ho H">HK Ho</name></author><author><name sortKey="Cabael, L" uniqKey="Cabael L">L Cabael</name></author><author><name sortKey="Hu, N" uniqKey="Hu N">N Hu</name></author><author><name sortKey="Sanislo, Sr" uniqKey="Sanislo S">SR Sanislo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Dossarps, D" uniqKey="Dossarps D">D Dossarps</name></author><author><name sortKey="Bron, Am" uniqKey="Bron A">AM Bron</name></author><author><name sortKey="Koehrer, P" uniqKey="Koehrer P">P Koehrer</name></author><author><name sortKey="Aho Glele, Ls" uniqKey="Aho Glele L">LS Aho-Glele</name></author><author><name sortKey="Creuzot Garcher, C" uniqKey="Creuzot Garcher C">C Creuzot-Garcher</name></author><author><name sortKey="Frcr, Net" uniqKey="Frcr N">Net FRCR</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sigford, Dk" uniqKey="Sigford D">DK Sigford</name></author><author><name sortKey="Reddy, S" uniqKey="Reddy S">S Reddy</name></author><author><name sortKey="Mollineaux, C" uniqKey="Mollineaux C">C Mollineaux</name></author><author><name sortKey="Schaal, S" uniqKey="Schaal S">S Schaal</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mccannel, Ca" uniqKey="Mccannel C">CA McCannel</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Fileta, Jb" uniqKey="Fileta J">JB Fileta</name></author><author><name sortKey="Scott, Iu" uniqKey="Scott I">IU Scott</name></author><author><name sortKey="Flynn, Hw" uniqKey="Flynn H">HW Flynn</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Moshfeghi, Aa" uniqKey="Moshfeghi A">AA Moshfeghi</name></author><author><name sortKey="Rosenfeld, Pj" uniqKey="Rosenfeld P">PJ Rosenfeld</name></author><author><name sortKey="Flynn, Hw" uniqKey="Flynn H">HW Flynn</name></author><author><name sortKey="Schwartz, Sg" uniqKey="Schwartz S">SG Schwartz</name></author><author><name sortKey="Davis, Jl" uniqKey="Davis J">JL Davis</name></author><author><name sortKey="Murray, Tg" uniqKey="Murray T">TG Murray</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bhavsar, Ar" uniqKey="Bhavsar A">AR Bhavsar</name></author><author><name sortKey="Googe, Jm" uniqKey="Googe J">JM Googe</name></author><author><name sortKey="Stockdale, Cr" uniqKey="Stockdale C">CR Stockdale</name></author><author><name sortKey="Bressler, Nm" uniqKey="Bressler N">NM Bressler</name></author><author><name sortKey="Brucker, Aj" uniqKey="Brucker A">AJ Brucker</name></author><author><name sortKey="Elman, Mj" uniqKey="Elman M">MJ Elman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cochereau, I" uniqKey="Cochereau I">I Cochereau</name></author><author><name sortKey="Korobelnik, Jf" uniqKey="Korobelnik J">JF Korobelnik</name></author><author><name sortKey="Bodaghi, B" uniqKey="Bodaghi B">B Bodaghi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Yin, Vt" uniqKey="Yin V">VT Yin</name></author><author><name sortKey="Weisbrod, Dj" uniqKey="Weisbrod D">DJ Weisbrod</name></author><author><name sortKey="Eng, Kt" uniqKey="Eng K">KT Eng</name></author><author><name sortKey="Schwartz, C" uniqKey="Schwartz C">C Schwartz</name></author><author><name sortKey="Kohly, R" uniqKey="Kohly R">R Kohly</name></author><author><name sortKey="Mandelcorn, E" uniqKey="Mandelcorn E">E Mandelcorn</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kim, Sj" uniqKey="Kim S">SJ Kim</name></author><author><name sortKey="Toma, Hs" uniqKey="Toma H">HS Toma</name></author><author><name sortKey="Midha, Nk" uniqKey="Midha N">NK Midha</name></author><author><name sortKey="Cherney, Ef" uniqKey="Cherney E">EF Cherney</name></author><author><name sortKey="Recchia, Fm" uniqKey="Recchia F">FM Recchia</name></author><author><name sortKey="Doherty, Tj" uniqKey="Doherty T">TJ Doherty</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cheung, Cs" uniqKey="Cheung C">CS Cheung</name></author><author><name sortKey="Wong, Aw" uniqKey="Wong A">AW Wong</name></author><author><name sortKey="Lui, A" uniqKey="Lui A">A Lui</name></author><author><name sortKey="Kertes, Pj" uniqKey="Kertes P">PJ Kertes</name></author><author><name sortKey="Devenyi, Rg" uniqKey="Devenyi R">RG Devenyi</name></author><author><name sortKey="Lam, Wc" uniqKey="Lam W">WC Lam</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Da Costa, Br" uniqKey="Da Costa B">BR da Costa</name></author><author><name sortKey="Cevallos, M" uniqKey="Cevallos M">M Cevallos</name></author><author><name sortKey="Altman, Dg" uniqKey="Altman D">DG Altman</name></author><author><name sortKey="Rutjes, Aw" uniqKey="Rutjes A">AW Rutjes</name></author><author><name sortKey="Egger, M" uniqKey="Egger M">M Egger</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Vandenbroucke, Jp" uniqKey="Vandenbroucke J">JP Vandenbroucke</name></author><author><name sortKey="Von Elm, E" uniqKey="Von Elm E">E von Elm</name></author><author><name sortKey="Altman, Dg" uniqKey="Altman D">DG Altman</name></author><author><name sortKey="Gotzsche, Pc" uniqKey="Gotzsche P">PC Gotzsche</name></author><author><name sortKey="Mulrow, Cd" uniqKey="Mulrow C">CD Mulrow</name></author><author><name sortKey="Pocock, Sj" uniqKey="Pocock S">SJ Pocock</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bhatt, Ss" uniqKey="Bhatt S">SS Bhatt</name></author><author><name sortKey="Stepien, Ke" uniqKey="Stepien K">KE Stepien</name></author><author><name sortKey="Joshi, K" uniqKey="Joshi K">K Joshi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Meredith, Ta" uniqKey="Meredith T">TA Meredith</name></author><author><name sortKey="Mccannel, Ca" uniqKey="Mccannel C">CA McCannel</name></author><author><name sortKey="Barr, C" uniqKey="Barr C">C Barr</name></author><author><name sortKey="Doft, Bh" uniqKey="Doft B">BH Doft</name></author><author><name sortKey="Peskin, E" uniqKey="Peskin E">E Peskin</name></author><author><name sortKey="Maguire, Mg" uniqKey="Maguire M">MG Maguire</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Pachuo, M" uniqKey="Pachuo M">M Pachuo</name></author><author><name sortKey="Sahto, A" uniqKey="Sahto A">A Sahto</name></author><author><name sortKey="Quraishi, M" uniqKey="Quraishi M">M Quraishi</name></author><author><name sortKey="Abbasi, A" uniqKey="Abbasi A">A Abbasi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Storey, P" uniqKey="Storey P">P Storey</name></author><author><name sortKey="Dollin, M" uniqKey="Dollin M">M Dollin</name></author><author><name sortKey="Pitcher, J" uniqKey="Pitcher J">J Pitcher</name></author><author><name sortKey="Reddy, S" uniqKey="Reddy S">S Reddy</name></author><author><name sortKey="Vojtko, J" uniqKey="Vojtko J">J Vojtko</name></author><author><name sortKey="Vander, J" uniqKey="Vander J">J Vander</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ramel, Jc" uniqKey="Ramel J">JC Ramel</name></author><author><name sortKey="Bron, Am" uniqKey="Bron A">AM Bron</name></author><author><name sortKey="Isaico, R" uniqKey="Isaico R">R Isaico</name></author><author><name sortKey="Meillon, C" uniqKey="Meillon C">C Meillon</name></author><author><name sortKey="Binquet, C" uniqKey="Binquet C">C Binquet</name></author><author><name sortKey="Creuzot Garcher, C" uniqKey="Creuzot Garcher C">C Creuzot-Garcher</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bhavsar, Ar" uniqKey="Bhavsar A">AR Bhavsar</name></author><author><name sortKey="Stockdale, Cr" uniqKey="Stockdale C">CR Stockdale</name></author><author><name sortKey="Ferris, Fl" uniqKey="Ferris F">FL Ferris</name></author><author><name sortKey="Brucker, Aj" uniqKey="Brucker A">AJ Brucker</name></author><author><name sortKey="Bressler, Nm" uniqKey="Bressler N">NM Bressler</name></author><author><name sortKey="Glassman, Ar" uniqKey="Glassman A">AR Glassman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Park, Y" uniqKey="Park Y">Y Park</name></author><author><name sortKey="Kim, Ks" uniqKey="Kim K">KS Kim</name></author><author><name sortKey="Park, Yh" uniqKey="Park Y">YH Park</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Stranak, Z" uniqKey="Stranak Z">Z Stranak</name></author><author><name sortKey="Veith, M" uniqKey="Veith M">M Veith</name></author><author><name sortKey="Studeny, P" uniqKey="Studeny P">P Studeny</name></author><author><name sortKey="Pencak, M" uniqKey="Pencak M">M Pencak</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mino De Kaspar, H" uniqKey="Mino De Kaspar H">H Mino De Kaspar</name></author><author><name sortKey="Hoepfner, As" uniqKey="Hoepfner A">AS Hoepfner</name></author><author><name sortKey="Engelbert, M" uniqKey="Engelbert M">M Engelbert</name></author><author><name sortKey="Thiel, M" uniqKey="Thiel M">M Thiel</name></author><author><name sortKey="Ta, Cn" uniqKey="Ta C">CN Ta</name></author><author><name sortKey="Mette, M" uniqKey="Mette M">M Mette</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Moss, Jm" uniqKey="Moss J">JM Moss</name></author><author><name sortKey="Sanislo, Sr" uniqKey="Sanislo S">SR Sanislo</name></author><author><name sortKey="Ta, Cn" uniqKey="Ta C">CN Ta</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Isenberg, Sj" uniqKey="Isenberg S">SJ Isenberg</name></author><author><name sortKey="Apt, L" uniqKey="Apt L">L Apt</name></author><author><name sortKey="Yoshimori, R" uniqKey="Yoshimori R">R Yoshimori</name></author><author><name sortKey="Khwarg, S" uniqKey="Khwarg S">S Khwarg</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kim, Sj" uniqKey="Kim S">SJ Kim</name></author><author><name sortKey="Toma, Hs" uniqKey="Toma H">HS Toma</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Costello, P" uniqKey="Costello P">P Costello</name></author><author><name sortKey="Bakri, Sj" uniqKey="Bakri S">SJ Bakri</name></author><author><name sortKey="Beer, Pm" uniqKey="Beer P">PM Beer</name></author><author><name sortKey="Singh, Rj" uniqKey="Singh R">RJ Singh</name></author><author><name sortKey="Falk, Ns" uniqKey="Falk N">NS Falk</name></author><author><name sortKey="Peters, Gb" uniqKey="Peters G">GB Peters</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bodaghi, B" uniqKey="Bodaghi B">B Bodaghi</name></author><author><name sortKey="Korobelnik, Jf" uniqKey="Korobelnik J">JF Korobelnik</name></author><author><name sortKey="Cochereau, I" uniqKey="Cochereau I">I Cochereau</name></author><author><name sortKey="Hajjar, J" uniqKey="Hajjar J">J Hajjar</name></author><author><name sortKey="Goebel, F" uniqKey="Goebel F">F Goebel</name></author><author><name sortKey="Dumarcet, N" uniqKey="Dumarcet N">N Dumarcet</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bhavsar, Ar" uniqKey="Bhavsar A">AR Bhavsar</name></author><author><name sortKey="Sandler, Dr" uniqKey="Sandler D">DR Sandler</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lelorier, J" uniqKey="Lelorier J">J LeLorier</name></author><author><name sortKey="Gregoire, G" uniqKey="Gregoire G">G Gregoire</name></author><author><name sortKey="Benhaddad, A" uniqKey="Benhaddad A">A Benhaddad</name></author><author><name sortKey="Lapierre, J" uniqKey="Lapierre J">J Lapierre</name></author><author><name sortKey="Derderian, F" uniqKey="Derderian F">F Derderian</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27257676</article-id><article-id pub-id-type="pmc">4892688</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0156431</article-id><article-id pub-id-type="publisher-id">PONE-D-16-02156</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drugs</subject><subj-group><subject>Antimicrobials</subject><subj-group><subject>Antibiotics</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Microbial Control</subject><subj-group><subject>Antimicrobials</subject><subj-group><subject>Antibiotics</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Mathematical and Statistical Techniques</subject><subj-group><subject>Statistical Methods</subject><subj-group><subject>Meta-Analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (Mathematics)</subject><subj-group><subject>Statistical Methods</subject><subj-group><subject>Meta-Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Microbial Control</subject><subj-group><subject>Antimicrobial Resistance</subject><subj-group><subject>Antibiotic Resistance</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Antimicrobial Resistance</subject><subj-group><subject>Antibiotic Resistance</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Database and Informatics Methods</subject><subj-group><subject>Database Searching</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Research Assessment</subject><subj-group><subject>Systematic Reviews</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Vaccination and Immunization</subject><subj-group><subject>Prophylaxis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Vaccination and Immunization</subject><subj-group><subject>Prophylaxis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Public and Occupational Health</subject><subj-group><subject>Preventive Medicine</subject><subj-group><subject>Vaccination and Immunization</subject><subj-group><subject>Prophylaxis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Bacteria</subject><subj-group><subject>Staphylococcus</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Bacterial Pathogens</subject><subj-group><subject>Staphylococcus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Bacterial Pathogens</subject><subj-group><subject>Staphylococcus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Bacteria</subject><subj-group><subject>Enterococcus</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Bacterial Pathogens</subject><subj-group><subject>Enterococcus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Bacterial Pathogens</subject><subj-group><subject>Enterococcus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Antibioprophylaxis in Prevention of Endophthalmitis in Intravitreal Injection: A Systematic Review and Meta-Analysis</article-title><alt-title alt-title-type="running-head">Antibioprophylaxis in Intravitreal Injections</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Benoist d’Azy</surname><given-names>Cédric</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pereira</surname><given-names>Bruno</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Naughton</surname><given-names>Geraldine</given-names></name><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chiambaretta</surname><given-names>Frédéric</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Dutheil</surname><given-names>Frédéric</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref><xref ref-type="aff" rid="aff005"><sup>5</sup></xref><xref ref-type="aff" rid="aff006"><sup>6</sup></xref><xref ref-type="aff" rid="aff007"><sup>7</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label><addr-line>University Hospital of Clermont-Ferrand (CHU), Ophthalmology, Clermont-Ferrand, France</addr-line></aff><aff id="aff002"><label>2</label><addr-line>University Hospital of Clermont-Ferrand (CHU), Preventive and Occupational Medicine, Clermont-Ferrand, France</addr-line></aff><aff id="aff003"><label>3</label><addr-line>University Hospital of Clermont-Ferrand (CHU), Clinical Research Direction, Clermont-Ferrand, France</addr-line></aff><aff id="aff004"><label>4</label><addr-line>Australian Catholic University, Faculty of Health, Melbourne, Victoria, Australia</addr-line></aff><aff id="aff005"><label>5</label><addr-line>Clermont Auvergne University, Blaise Pascal University, Laboratory of Metabolic Adaptations to Exercise in Physiological and Pathological conditions EA3533, Clermont-Ferrand, France</addr-line></aff><aff id="aff006"><label>6</label><addr-line>Research Centre in Human Nutrition (CRNH) Auvergne, Clermont-Ferrand, France</addr-line></aff><aff id="aff007"><label>7</label><addr-line>CNRS, UMR 6024, Physiological and Psychosocial Stress, LAPSCO, University Clermont Auvergne, Clermont-Ferrand, France</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Mori</surname><given-names>Keisuke</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"></xref></contrib></contrib-group><aff id="edit1"><addr-line>International University of Health and Welfare, JAPAN</addr-line></aff><author-notes><fn fn-type="conflict" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con" id="contrib001"><p>Conceived and designed the experiments: CBDA FD. Performed the experiments: CBDA FD. Analyzed the data: CBDA BP FD. Contributed reagents/materials/analysis tools: CBDA BP GN FC FD. Wrote the paper: CBDA FD. Integrity of the data analysis: CBDA FD.</p></fn><corresp id="cor001">* E-mail: <email>frederic.dutheil@acu.edu.au</email></corresp></author-notes><pub-date pub-type="epub"><day>3</day><month>6</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>11</volume><issue>6</issue><elocation-id>e0156431</elocation-id><history><date date-type="received"><day>16</day><month>1</month><year>2016</year></date><date date-type="accepted"><day>13</day><month>5</month><year>2016</year></date></history><permissions><copyright-statement>© 2016 Benoist d’Azy et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Benoist d’Azy et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0156431.pdf"></self-uri><abstract><p>Despite endophthalmitis being the most feared complication, antibioprophylaxis remains controversial in intravitreal injections. Therefore, we conducted a systematic review and meta-analysis on the effects of antibioprophylaxis in intravitreal injections in the prevention of endophthalmitis. The PubMed, Cochrane Library, Embase and Science Direct databases were searched for studies comparing groups with and without antibiotics in intravitreal injection, with the use of the following keywords: "antibiotic*", "endophthalmitis" and “intravitreal injection*”. To be included, studies needed to specify number of participants and number of endophthalmitis within each group (with and without antibiotics). We conducted meta-analysis on the prevalence of clinical endophthalmitis including both culture-proven and culture negative samples. Nine studies were included. A total of 88 incidences of endophthalmitis were reported from 174,159 injections (0.051% i.e., one incidence of endophthalmitis for 1979 injections). Specifically, 59 incidences of endophthalmitis were reported from 113,530 injections in the group with antibiotics (0.052% or one incidence of endophthalmitis for 1924 injections) and 29 incidences of endophthalmitis from 60,633 injections in the group without antibiotics (0.048% or one endophthalmitis for 2091 injections). Our meta-analysis did not report a significant difference in the prevalence of clinical endophthalimitis between the two groups with and without topical antibiotics: the odds ratio of clinical endophthalimitis was 0.804 (CI95% 0.384–1.682, p = 0.56) for the antibiotic group compared with the group without antibiotics. In conclusion, we performed the first large meta-analysis demonstrating that antibioprophylaxis is not required in intravitreal injections. Strict rules of asepsis remain the only evidence-based prophylaxis of endophthalmitis. The results support initiatives to reduce the global threat of resistance to antibiotics.</p></abstract><funding-group><funding-statement>This study was funded by the University Hospital of Clermont-Ferrand, France.</funding-statement></funding-group><counts><fig-count count="3"></fig-count><table-count count="2"></table-count><page-count count="12"></page-count></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Anti-VEGF intravitreal injections have demonstrated a relative efficacy to treat common diseases such as wet age-related macular degeneration, diabetic macular edema and central and branch retinal vein occlusion [<xref rid="pone.0156431.ref001" ref-type="bibr">1</xref>]. Therefore, intravitreal injections are a common medical procedure, performed annually by millions across industrialized countries [<xref rid="pone.0156431.ref002" ref-type="bibr">2</xref>]. Transfixing perforation of the sclera of the eye by the injection needle might lead to infectious complications, specifically endophthalmitis [<xref rid="pone.0156431.ref003" ref-type="bibr">3</xref>]. Although rare [<xref rid="pone.0156431.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0156431.ref005" ref-type="bibr">5</xref>,<xref rid="pone.0156431.ref006" ref-type="bibr">6</xref>,<xref rid="pone.0156431.ref007" ref-type="bibr">7</xref>], endophthalmitis is the most feared complication of intravitreal injections due to its poor functional prognosis [<xref rid="pone.0156431.ref008" ref-type="bibr">8</xref>]. Strategies for infection prophylaxis are generally based on the use of antiseptics and antibiotics. Regarding antiseptics, the use of povidone-iodine to the ocular surface along with aseptic techniques in anterior segment surgery have been the only type of intervention shown to be moderately important in reducing the risk of post-operative endophthalmitis [<xref rid="pone.0156431.ref009" ref-type="bibr">9</xref>]. However, the use of antibiotics remains under debate. Despite the absence of evidence-based data, the common clinical practice involved topical antibiotics before, concurrently with, or after the intravitreal injection [<xref rid="pone.0156431.ref010" ref-type="bibr">10</xref>]. The usefulness of antibiotics in the prevention of endophthalmitis after intravitreal injections has been more recently questioned. No prospective randomized study demonstrated the benefits of topical antibiotics. Additionally, topical antibiotics enhanced rapid development of antibiotic-resistant virulent bacteria on the ocular surface and spreading in the oral sphere [<xref rid="pone.0156431.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0156431.ref012" ref-type="bibr">12</xref>].</p><p>Despite the absence of data to support the reduction of endophthalmitis through the use of antibiotics after intravitreal injection, many ophthalmologists continue to recommend a multiday course of topical antibiotic use after intravitreal injection. Therefore, because antibiotics can be unecessary and detrimental [<xref rid="pone.0156431.ref013" ref-type="bibr">13</xref>], we aimed to conduct a systematic review and meta-analysis on putative benefits of antibiotic prophylaxis in preventing endophthalmitis after intravitreal injections, and to strengthen the evidence base for establishing international guidelines.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Methods</title><sec id="sec003"><title>Literature Search</title><p>We reviewed all cohort studies found on Medline via Pubmed that compared two groups after intravitreal injections: one with antibiotics and one without. Keywords for the search strategy were "antibiotic*", "endophthalmitis" and “intravitreal injection*”. The following databases were searched on December 23<sup>rd</sup>, 2015: PubMed, Cochrane Library, Science Direct and Embase. The search was not limited to specific years and no language restrictions applied. To be included, studies needed to specify the number of participants and quantify the incidence of endophthalmitis within each group (with and without antibiotics). All kinds of intravitreal injections were included i.e. corticoids (triamcinolone, dexamethasone) or anti-VEGF such as monoclonal antibodies (mab–bevacizumab, ranibizumab), recombinant proteins (aflibercept) and pegatnamib. In addition, reference lists of all publications meeting the inclusion criteria were manually searched to identify any further studies not identified via electronic searching. The search strategy is described in <xref ref-type="fig" rid="pone.0156431.g001">Fig 1</xref>. One author (CBA) conducted all literature searches and collated the abstracts. Two authors (CBA and FD) separately reviewed the abstracts and based on the selection criteria, decided the suitability of the articles for inclusion. A third author (GN) was asked to review the article where consensus on suitability was not met. Then, all authors reviewed the eligible articles.</p><fig id="pone.0156431.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0156431.g001</object-id><label>Fig 1</label><caption><title>Search strategy.</title></caption><graphic xlink:href="pone.0156431.g001"></graphic></fig></sec><sec id="sec004"><title>Quality of assessment</title><p>Although not designed for quantifying the integrity of studies [<xref rid="pone.0156431.ref014" ref-type="bibr">14</xref>], the “STrengthening the Reporting of OBservational studies in Epidemiology” (STROBE) criteria were used for checking the quality of reporting [<xref rid="pone.0156431.ref015" ref-type="bibr">15</xref>]. The 22 items identified in the STROBE criteria could gain achieve a maximal score of 33.</p></sec><sec id="sec005"><title>Statistical considerations</title><p>Statistical analysis was conducted using Comprehensive Meta-analysis software (version 2, Biostat Corporation) and Stata software (version 13, StataCorp, College Station, US). Extracted data were summarized for each study and reported as mean (standard-deviation) and number (%) for continuous and categorical variables respectively. Prevalence of endophthalmitis and 95% confidence intervals were estimated using random-effects models assuming between and within study variability (DerSimonian and Laird approach). Statistical heterogeneity between results was assessed using forest plots, confidence intervals and I². The I<sup>2</sup> statistic is the most common metric for measuring the magnitude of between-study heterogeneity and is easily interpretable. I² values range between 0 and 100% and are typically considered low for values <25%, modest for 25–50%, and high for >50%. This statistical method generally assumes heterogeneity when the p-value of the I² test is <0.05. A sensitivity analysis was thus conducted to assess the influence on the global prevalence of the inclusion and exclusion of studies. Then, we conducted a meta-analysis on the prevalence of clinical endophthalmitis including both culture-proven and culture negative samples and where possible (sufficient sample size), on the prevalence of endophthalmitis depending on the type of products used for intravitreal injections (taking into account antibiotics prescription), and on the type of germs identified if the culture was positive. We also aimed to propose meta-regressions too investigate relations between the prevalence and clinically relevant parameters according to the literature. Results were expressed as regression coefficients and 95% confidence intervals. Type I-error was fixed at a = 0.05.</p></sec></sec><sec sec-type="results" id="sec006"><title>Results</title><p>An initial search produced a possible for 943 articles. Removal of duplicates and selection criteria reduced the articles comparing two groups to nine articles (<xref ref-type="fig" rid="pone.0156431.g001">Fig 1</xref> and <xref ref-type="table" rid="pone.0156431.t001">Table 1</xref>).</p><table-wrap id="pone.0156431.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0156431.t001</object-id><label>Table 1</label><caption><title>Repartition of culture in the 2 groups in each study and prevalence of endophthalmitis in each study.</title></caption><alternatives><graphic id="pone.0156431.t001g" xlink:href="pone.0156431.t001"></graphic><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col></colgroup><thead><tr><th align="center" rowspan="2" colspan="1">Study</th><th align="center" colspan="3" rowspan="1">Total</th><th align="center" colspan="3" rowspan="1">Group with antibiotic</th><th align="center" colspan="3" rowspan="1">Group without antibiotic</th></tr><tr><th align="center" rowspan="1" colspan="1">Number of endophthalmitis / Number of injections</th><th align="center" rowspan="1" colspan="1">Culture (+)</th><th align="center" rowspan="1" colspan="1">Culture (-)</th><th align="center" rowspan="1" colspan="1">Number of endophthalmitis / Number of injections</th><th align="center" rowspan="1" colspan="1">Culture (+)</th><th align="center" rowspan="1" colspan="1">Culture (-)</th><th align="center" rowspan="1" colspan="1">Number of endophthalmitis / Number of injections</th><th align="center" rowspan="1" colspan="1">Culture (+)</th><th align="center" rowspan="1" colspan="1">Culture (-)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Bhatt et al, 2011</td><td align="center" rowspan="1" colspan="1">10/4767</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">5/2287</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">5/2480</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">Bhavsar et al, 2012</td><td align="center" rowspan="1" colspan="1">7/8027</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">6/4697</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1/3333</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Cheung et al, 2012</td><td align="center" rowspan="1" colspan="1">9/15895</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">7/10629</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">2/5266</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Meredith et al, 2015<xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="center" rowspan="1" colspan="1">11/18509</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">8/16509</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">3/2000</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Pachuo et al, 2015</td><td align="center" rowspan="1" colspan="1">0/620</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0/310</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0/310</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Park et al, 2013</td><td align="center" rowspan="1" colspan="1">3/17332</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0/8649</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3/8683</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Ramel et al, 2014</td><td align="center" rowspan="1" colspan="1">6/11450</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">3/10144</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">3/1306</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Storey et al, 2014<xref ref-type="table-fn" rid="t001fn002">**</xref></td><td align="center" rowspan="1" colspan="1">39/92554</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">28/57654</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">11/34900</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">7</td></tr><tr><td align="left" rowspan="1" colspan="1">Stranak et al, 2014</td><td align="center" rowspan="1" colspan="1">3/5005</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2/2651</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1/2355</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Total</bold></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"> Number</td><td align="center" rowspan="1" colspan="1">88/174159</td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">59/113530</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">29/60633</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1"> Prevalence (%)</td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">0.021</td><td align="center" rowspan="1" colspan="1">0.029</td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">0.020</td><td align="center" rowspan="1" colspan="1">0.031</td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">0.023</td><td align="center" rowspan="1" colspan="1">0.018</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>* 1 endophthalmitis had not culture results</p></fn><fn id="t001fn002"><p>** Transition period with unknown antibiotic prescription was excluded</p></fn></table-wrap-foot></table-wrap><sec id="sec007"><title>Quality of articles</title><p>Quality assessment of the nine included studies was analyzed by the STROBE criteria, from which results varied from 57.6 to 94.0%, with a mean score of 77.1±13.7%. Overall, the studies performed best in the discussion section and worst in the methods section.</p></sec><sec id="sec008"><title>Population</title><sec id="sec009"><title>Sample size</title><p>Only two studies reported the number of patients i.e. 4767 [<xref rid="pone.0156431.ref016" ref-type="bibr">16</xref>] and 1185 participants [<xref rid="pone.0156431.ref017" ref-type="bibr">17</xref>]. All studies reported the total number of injections ranging from 620 [<xref rid="pone.0156431.ref018" ref-type="bibr">18</xref>] to 92,554 [<xref rid="pone.0156431.ref019" ref-type="bibr">19</xref>]. Overall, our current meta-analyses included a total of 174,159 injections: 113,530 with antibiotics and 60,633 without antibiotics (<xref ref-type="table" rid="pone.0156431.t001">Table 1</xref>).</p></sec><sec id="sec010"><title>Age</title><p>Only two studies reported the median age within patients; specifically 72.2 [<xref rid="pone.0156431.ref013" ref-type="bibr">13</xref>] and 79.3 [<xref rid="pone.0156431.ref020" ref-type="bibr">20</xref>] years old. A third study reported an age of the population ranging from 30 to 70 years old, but did not specify a mean or median age [<xref rid="pone.0156431.ref018" ref-type="bibr">18</xref>]. Other studies did not provide any information on the age of patients.</p></sec><sec id="sec011"><title>Gender</title><p>Gender was not specified in all of the nine retrieved studies.</p></sec></sec><sec id="sec012"><title>Intravitreal injections</title><sec id="sec013"><title>Indications for injections</title><p>Four studies provided details of the indications for injections which were exudative age-related macular degeneration [<xref rid="pone.0156431.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0156431.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0156431.ref018" ref-type="bibr">18</xref>], choroidal neovascular membranes secondary to myopic degeneration [<xref rid="pone.0156431.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0156431.ref018" ref-type="bibr">18</xref>], macular edema secondary to diabetes [<xref rid="pone.0156431.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0156431.ref018" ref-type="bibr">18</xref>,<xref rid="pone.0156431.ref021" ref-type="bibr">21</xref>], central and branch retinal vein occlusions [<xref rid="pone.0156431.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0156431.ref018" ref-type="bibr">18</xref>], uveitis [<xref rid="pone.0156431.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0156431.ref018" ref-type="bibr">18</xref>], birdshot chorioretinopathy [<xref rid="pone.0156431.ref013" ref-type="bibr">13</xref>] and other proliferative retinopathies [<xref rid="pone.0156431.ref013" ref-type="bibr">13</xref>]. The five other studies included all patients needing intravitreal injections but did not specify more detailed indications [<xref rid="pone.0156431.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0156431.ref019" ref-type="bibr">19</xref>,<xref rid="pone.0156431.ref020" ref-type="bibr">20</xref>,<xref rid="pone.0156431.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0156431.ref023" ref-type="bibr">23</xref>].</p></sec><sec id="sec014"><title>Type of products injected</title><p>all studies reported injections of bevacizumab except one [<xref rid="pone.0156431.ref021" ref-type="bibr">21</xref>], all studies reported injections of ranibizumab except one [<xref rid="pone.0156431.ref018" ref-type="bibr">18</xref>], six studies used triamcinolone injections [<xref rid="pone.0156431.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0156431.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0156431.ref020" ref-type="bibr">20</xref>,<xref rid="pone.0156431.ref021" ref-type="bibr">21</xref>,<xref rid="pone.0156431.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0156431.ref023" ref-type="bibr">23</xref>], three studies reported pegatnamib injections [<xref rid="pone.0156431.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0156431.ref020" ref-type="bibr">20</xref>,<xref rid="pone.0156431.ref023" ref-type="bibr">23</xref>], one gave aflibercept [<xref rid="pone.0156431.ref019" ref-type="bibr">19</xref>], one reported dexamethasone injections [<xref rid="pone.0156431.ref023" ref-type="bibr">23</xref>] and one reported a C3F8 injection [<xref rid="pone.0156431.ref022" ref-type="bibr">22</xref>]. Among the studies reporting multiple products within the injection, five combined injections of bevacizumab, ranibizumab and triamcinolone [<xref rid="pone.0156431.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0156431.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0156431.ref020" ref-type="bibr">20</xref>,<xref rid="pone.0156431.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0156431.ref023" ref-type="bibr">23</xref>], three combined bevacizumab, ranibizumab, triamcinolone and pegatnamib [<xref rid="pone.0156431.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0156431.ref020" ref-type="bibr">20</xref>,<xref rid="pone.0156431.ref023" ref-type="bibr">23</xref>], one reported simultaneously ranibizumab and triamcinolone [<xref rid="pone.0156431.ref021" ref-type="bibr">21</xref>], and one bevacizumab and ranibizumab [<xref rid="pone.0156431.ref019" ref-type="bibr">19</xref>]. However, only one of these studies reported the sample size with and without antibiotics within each group of type of products injected [<xref rid="pone.0156431.ref019" ref-type="bibr">19</xref>]. Subsequently, more advanced meta-analyses were unable to be conducted.</p></sec></sec><sec id="sec015"><title>Antibiotics use</title><p>All included articles reported only topical antibiotics, with the exception of one study which also administrated one oral dose of antibiotic post injection (ciprofloxacin 500 mg) during three days in addition to topical antibiotics [<xref rid="pone.0156431.ref018" ref-type="bibr">18</xref>]. One study prescribed topical antibiotics only for the three days <italic>preceding the</italic> intravitreal injection [<xref rid="pone.0156431.ref022" ref-type="bibr">22</xref>]. Another study used a topical antibiotic <italic>before and after the injection</italic> (levofloxacin 5 times daily the 3 days before and the 3 days after injection) [<xref rid="pone.0156431.ref023" ref-type="bibr">23</xref>]. Four studies administered antibiotics <italic>during and after</italic> the injection (one drop immediately at the end of procedure and then a 4<sup>th</sup> generation fluoroquinolone after 3 or 5 days [<xref rid="pone.0156431.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0156431.ref016" ref-type="bibr">16</xref>] or tobramycin 4 times daily during 4 days [<xref rid="pone.0156431.ref020" ref-type="bibr">20</xref>] or azithromycin twice daily during 3 days [<xref rid="pone.0156431.ref020" ref-type="bibr">20</xref>] or others left the prescription of topical antibiotics to the discretion of individual physicians). Finally, one article reported antibiotics only <italic>after</italic> the injection (4 times daily during 4 days) [<xref rid="pone.0156431.ref019" ref-type="bibr">19</xref>]. Two articles left the prescription of topical antibiotics to the discretion of physicians, and thus did not specify whether antibiotics were administered before, during or after intravitreal injection [<xref rid="pone.0156431.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0156431.ref021" ref-type="bibr">21</xref>]. One study reported a transition period in which the antibiotic prescription was unknown; excluding this transition period from our meta-analyses [<xref rid="pone.0156431.ref019" ref-type="bibr">19</xref>].</p></sec><sec id="sec016"><title>Bacteriology</title><p><italic>Staphylococcus</italic> and <italic>streptococcus</italic> are the most frequent germs found in culture-proven endophthalmitis (47.5% and 35%, respectively) (<xref ref-type="table" rid="pone.0156431.t002">Table 2</xref>). Enterococcus was found within two studies [<xref rid="pone.0156431.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0156431.ref019" ref-type="bibr">19</xref>], and only one lactobacillus was found out of 37 culure-proven endophthalmitis [<xref rid="pone.0156431.ref019" ref-type="bibr">19</xref>].</p><table-wrap id="pone.0156431.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0156431.t002</object-id><label>Table 2</label><caption><title>Bacteria found in culture proven endophthalmitis.</title></caption><alternatives><graphic id="pone.0156431.t002g" xlink:href="pone.0156431.t002"></graphic><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col></colgroup><thead><tr><th align="center" rowspan="2" colspan="1">Study</th><th align="center" rowspan="1" colspan="1">Culture</th><th align="center" colspan="4" rowspan="1">Group with antibiotic</th><th align="center" colspan="4" rowspan="1">Group without antibiotic</th></tr><tr><th align="center" rowspan="1" colspan="1">(+)</th><th align="center" rowspan="1" colspan="1">Staphylococcus</th><th align="center" rowspan="1" colspan="1">Streptococcus</th><th align="center" rowspan="1" colspan="1">Enterococcus</th><th align="center" rowspan="1" colspan="1">lactobacillus</th><th align="center" rowspan="1" colspan="1">Staphylococcus</th><th align="center" rowspan="1" colspan="1">Streptococcus</th><th align="center" rowspan="1" colspan="1">Enterococcus</th><th align="center" rowspan="1" colspan="1">lactobacillus</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Bhatt et al, 2011</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Bhavsar et al, 2012</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Cheung et al, 2012</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Meredith et al, 2015</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Pachuo et al, 2015</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Park et al, 2013</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Ramel et al, 2014</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Storey et al, 2014<xref ref-type="table-fn" rid="t002fn001">*</xref></td><td align="center" rowspan="1" colspan="1">14<xref ref-type="table-fn" rid="t002fn002">**</xref></td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Stranak et al, 2014</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Total</bold></td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>* Transition period with unknown antibiotic prescription was excluded</p></fn><fn id="t002fn002"><p>** 1 culture was non differentiated gram-positive cocci</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec017"><title>Outcomes and aims of the studies</title><p>The primary outcome was the incidence of endophthalmitis between two groups: one with antibiotics and one without. Secondary outcomes were clearly defined in two studies and involved investigations of the microbial spectrum [<xref rid="pone.0156431.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0156431.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0156431.ref019" ref-type="bibr">19</xref>] and clinical outcomes including return to baseline visual acuity [<xref rid="pone.0156431.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0156431.ref019" ref-type="bibr">19</xref>]. However, other studies also described microbial spectrum [<xref rid="pone.0156431.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0156431.ref018" ref-type="bibr">18</xref>,<xref rid="pone.0156431.ref020" ref-type="bibr">20</xref>,<xref rid="pone.0156431.ref021" ref-type="bibr">21</xref>,<xref rid="pone.0156431.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0156431.ref023" ref-type="bibr">23</xref>] and four studies reported the number of endophthalmitis for each product used [<xref rid="pone.0156431.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0156431.ref019" ref-type="bibr">19</xref>,<xref rid="pone.0156431.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0156431.ref023" ref-type="bibr">23</xref>]. However, whether it was in group with or without antibiotics was unclear.</p></sec><sec id="sec018"><title>Study designs</title><p>Six studies were retrospective [<xref rid="pone.0156431.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0156431.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0156431.ref019" ref-type="bibr">19</xref>,<xref rid="pone.0156431.ref020" ref-type="bibr">20</xref>,<xref rid="pone.0156431.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0156431.ref023" ref-type="bibr">23</xref>] and three were prospective [<xref rid="pone.0156431.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0156431.ref018" ref-type="bibr">18</xref>,<xref rid="pone.0156431.ref021" ref-type="bibr">21</xref>]. All studies were published after 2011; with the duration of follow-up ranging from 12 [<xref rid="pone.0156431.ref018" ref-type="bibr">18</xref>] to 108 months [<xref rid="pone.0156431.ref021" ref-type="bibr">21</xref>].</p></sec><sec id="sec019"><title>Meta-analysis on prevalence of clinical endopthalmitis</title><p>A total of 88 incidences of endophthalmitis were reported from the 174,159 injections (0.051% or one incidence of endophthalmitis from 1979 injections), ranging from 0/620 (0%) [<xref rid="pone.0156431.ref018" ref-type="bibr">18</xref>] to 1/477 (0.21%) [<xref rid="pone.0156431.ref016" ref-type="bibr">16</xref>]. Specifically, 59 endophthalmitis were reported from 113,530 injections in the group with antibiotics (0.052% or one incidence of endophthalmitis from 1924 injections) and 29 endophthalmitis from 60,633 injections in the group without antibiotics (0.048% or one incidence of endophthalmitis from 2091 injections) (<xref ref-type="table" rid="pone.0156431.t001">Table 1</xref>). Our meta-analysis did not report a significant difference in the prevalence of clinical endophthalimitis between the two groups with and without topical antibiotics: the odds ratio of clinical endophthalimitis was 0.804 (CI95% 0.384–1.682, p = 0.56) for the antibiotics group compared with the group without antibiotics, with moderate heterogeneity between studies (I-squared = 47.2%, p = .056) (<xref ref-type="fig" rid="pone.0156431.g002">Fig 2</xref>).</p><fig id="pone.0156431.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0156431.g002</object-id><label>Fig 2</label><caption><title>Odd ratio for each study including both culture-proven and culture negative endophthalmitis.</title></caption><graphic xlink:href="pone.0156431.g002"></graphic></fig></sec><sec id="sec020"><title>Meta-analysis on prevalence of culture-proven endopthalmitis</title><p>When considering only culture-proven endophthalmitis, a total of 37 incidences of culture-proven endophthalmitis were reported from 174,159 injections (0.021% or one incidence of endophthalmitis from 4,707 injections) and thus, a total of 50 culture-negative cases of suspected endophthalmitis were reported from 174,159 injections (0.029% or one incidence of endophthalmitis from 3,483 injections) (one described case of endophthalmitis lacked culture results) (<xref ref-type="table" rid="pone.0156431.t001">Table 1</xref>) [<xref rid="pone.0156431.ref017" ref-type="bibr">17</xref>]. Specifically, 23 culture-proven endophthalmitis were reported from 113,530 injections in the group with antibiotics (0.020% or one incidence of endophthalmitis from 4,936 injections) and 14 incidences of culture-proven endophthalmitis from 60,633 injections in the group without antibiotics (0.023% ior one incidence of endophthalmitis from 4,331 injections). Including only culture-negative cases, 35 culture-negative incidences of endophthalmitis were reported from 113,530 injections in the group with antibiotics (0.031% or one incidence of endophthalmitis from 3,244 injections) and 15 incidences of culture-proven endophthalmitis from 60,633 injections in the group without antibiotics (0.025% or one incidence of endophthalmitis from 4,042 injections). Our meta-analysis did not report a significant difference in the incidence of culture-proven endophthalimitis between the 2 groups with and without topical antibiotics: the odd ratio of culture-proven endophthalimitis was 0.552 (CI 95% 0.240–1.265, p = 0.160) for the antibiotics group compared with the group without antibiotics; with low heterogeneity between studies (I-squared = 20.1%, p = 0.177) (<xref ref-type="fig" rid="pone.0156431.g003">Fig 3</xref>).</p><fig id="pone.0156431.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0156431.g003</object-id><label>Fig 3</label><caption><title>Odd ratio for each study including only culture-proven endophthalmitis.</title></caption><graphic xlink:href="pone.0156431.g003"></graphic></fig></sec><sec id="sec021"><title>Other meta-analyses and meta-regressions</title><p>An insufficient number of studies reported the specific types of antibiotics used and types of products injected (bevacizumab, ranibizumab, triamcinolone). Therefore, low numbers of studies precluded meta-analyses on the influence of types of products injected to reduce the risk of endophthalmitis. Insufficient sample sizes also precluded meta-analyses on bacteries retrieved in culture proven endophthalmitis. Similarly, only two studies reported the number of patients, only two studies reported age, and no studies reported gender (<xref ref-type="supplementary-material" rid="pone.0156431.s002">S1 Database</xref>). Consequently, no meta-regressions were conducted.</p></sec></sec><sec sec-type="conclusions" id="sec022"><title>Discussion</title><p>This current study is the first large meta-analysis on the effectiveness of antibioprophylaxis in the prevention of endophthalmitis via intravitreal injection. We included a total of 174,159 injections, with a 0.052% or one incidence of endophthalmitis from 1924 injections) in the group with antibiotics and 0.048% or one incidence of endophthalmitis from 2091 injections in the group without antibiotics. The major finding ere was the absence of difference in the incidence of endophthalmitis with and without antibioprophylaxis (OR = 0.804, CI95% 0.384–1.682, p = 0.56) for the antibiotic group compared with the group without antibiotics; with a moderate heterogeneity between studies (I-squared = 47.2%, p = .056).</p><sec id="sec023"><title>The threat of antibiotics</title><p>Repeated use of antiobioprophylaxis, such as in monthly intravitreal injections, promote resistance [<xref rid="pone.0156431.ref011" ref-type="bibr">11</xref>] and virulence [<xref rid="pone.0156431.ref024" ref-type="bibr">24</xref>] of the conjunctival flora, even on short durations with low doses [<xref rid="pone.0156431.ref024" ref-type="bibr">24</xref>]. The minimum inhibitory concentration of antibiotics at the conjunctival flora increased in patients receiving antibiotics after the third injection [<xref rid="pone.0156431.ref011" ref-type="bibr">11</xref>]. Moreover, topical antibiotics and povidone–iodine before intravitreal injections did not further reduce bacterial concentrations compared with povidone–iodine alone [<xref rid="pone.0156431.ref025" ref-type="bibr">25</xref>]. Therefore, some authors calculated the sample size required to perform a non-inferiority test of antiseptics compared with antibiotics, ranged from 25,000 [<xref rid="pone.0156431.ref013" ref-type="bibr">13</xref>] to 50,000 [<xref rid="pone.0156431.ref020" ref-type="bibr">20</xref>] injections per group. In addition, a single application of povidone–iodine demonstrated a bactericidal effect equivalent to a 3-day course of topical antibiotics [<xref rid="pone.0156431.ref026" ref-type="bibr">26</xref>]. Also, repeated topical antibiotics applications may cause resistance in the nasopharynx [<xref rid="pone.0156431.ref027" ref-type="bibr">27</xref>]. Pharmacologically, intravitreal penetration of topical antibiotic is below the minimum inhibitory concentration required for a therapeutic effect [<xref rid="pone.0156431.ref028" ref-type="bibr">28</xref>]. Finally, systematic use of topical antibiotics generates a substantial cost, both for patients and society. The evidence-based strategy for preventing endophthalmitis remains the use of an eyelid speculum, povidone-iodine, surgical mask and sterile gloves [<xref rid="pone.0156431.ref029" ref-type="bibr">29</xref>].</p></sec><sec id="sec024"><title>Promoting guideline for antibioprophy</title><p>This is the first large meta-analysis demonstrating the absence of systematic antibioprophylaxis in prevention of endophthalmitis in intravitreal injections. The moderate heterogeneity reported in our study is due to the low incidence of endophthalmitis; ranging from 0 [<xref rid="pone.0156431.ref018" ref-type="bibr">18</xref>] to 0.21% [<xref rid="pone.0156431.ref016" ref-type="bibr">16</xref>]. Even if the study of Dorssaps et al (2015) could not have been included in our meta-analyses because it did not report numbers of endophthalmitis and total number of intravitreal injections within a group with and without antibiotics, authors reported that the use of an antibiotic or antiseptic increased the incidence of endophthalmitis (relative risk = 2.77, CI95% 1.54–5.00, p = .001) [<xref rid="pone.0156431.ref004" ref-type="bibr">4</xref>]. Moreover, we must acknowledge that the study of Dorssaps et al (2015) was conducted over 25 centers and included more than 300,000 intravitreal injections [<xref rid="pone.0156431.ref004" ref-type="bibr">4</xref>]. Therefore, despite the absence of guidelines regarding use the antibiotics in intravitreal injections, some ophthalmologists recently stopped antibioprophylaxis. Also some ophthalmologists reported a low incidence of endophthalmitis can be achieved in the absence of topical antibiotics [<xref rid="pone.0156431.ref030" ref-type="bibr">30</xref>]. Moreover, one of the lowest incidences of endophthalmitis in the literature was reported in this study that included a large sample size of intravitreal injections without antibiotics; resulting in only one incidence of endophthalmitis from 18,839 injections (0.0053%) [<xref rid="pone.0156431.ref030" ref-type="bibr">30</xref>].</p></sec><sec id="sec025"><title>Limitations</title><p>All meta-analyses have limitations [<xref rid="pone.0156431.ref031" ref-type="bibr">31</xref>]. Meta-analyses inherit the limitations of the individual studies of which they are composed. The low number of prospective studies reported the lowest number of injections. Antibiotic treatment protocols differed between selected studies and insufficient data precluded further analyses on protocols used. The incidence of culture-negative endophthalmitis may seem high however, it is similar to literature (0.022%) [<xref rid="pone.0156431.ref005" ref-type="bibr">5</xref>]. Even if non-significant, the culture-proven endophthalimitis odds ratio of 0.552 (CI 95% 0.240–1.265, p = 0.160) for the antibiotics group compared with the group without antibiotics may limit generalizability. However, in real practice, all endophthalmitis generate an undesirable prognosis (including culture negative endophthalmitis) [<xref rid="pone.0156431.ref019" ref-type="bibr">19</xref>]. A large multicenter prospective cluster randomized controlled trial, with consistent protocols, would help promote international guidelines; nonetheless the sample size required would make this study problematic to manage. Preliminary plans to target sub-group analyses for types of antibiotic used, products injected, and the bacteria retrieved in culture-proven endophthalmitis, were not feasible due to insufficient numbers of studies with these details.</p></sec></sec><sec sec-type="conclusions" id="sec026"><title>Conclusion</title><p>We performed the first large meta-analysis demonstrating that antibioprophylaxis treatment is not required in intravitreal injections. Strict rules of asepsis remain the only evidence-based support for prophylaxis of endophthalmitis. The results support initiatives to reduce the global threat of resistance to antibiotics. Therefore, antibiotics should be prescribed only in exceptional cases such as immunosuppression or fragile conjunctiva. International guidelines surrounding the use of antibiotics in intravitreal injections should be generated.</p></sec><sec sec-type="supplementary-material" id="sec027"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0156431.s001"><label>S1 PRISMA Checklist</label><caption><title>PRISMA Checklist.</title><p>(DOCX)</p></caption><media xlink:href="pone.0156431.s001.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0156431.s002"><label>S1 Database</label><caption><title>Crude data of all the included studies.</title><p>Titles of columns are written without abbreviations.</p><p>(XLSX)</p></caption><media xlink:href="pone.0156431.s002.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>This study was funded by the University Hospital of Clermont-Ferrand, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></ack><ref-list><title>References</title><ref id="pone.0156431.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Avery</surname><given-names>RL</given-names></name>, <name><surname>Bakri</surname><given-names>SJ</given-names></name>, <name><surname>Blumenkranz</surname><given-names>MS</given-names></name>, <name><surname>Brucker</surname><given-names>AJ</given-names></name>, <name><surname>Cunningham</surname><given-names>ET</given-names><suffix>Jr</suffix></name>, <name><surname>D'Amico</surname><given-names>DJ</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Intravitreal injection technique and monitoring: updated guidelines of an expert panel</article-title>. <source>Retina 34 Suppl</source><volume>12</volume>: <fpage>S1</fpage>–<lpage>S18</lpage>.</mixed-citation></ref><ref id="pone.0156431.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Wykoff</surname><given-names>CC</given-names></name>, <name><surname>Flynn</surname><given-names>HW</given-names><suffix>Jr</suffix></name>, <name><surname>Rosenfeld</surname><given-names>PJ</given-names></name> (<year>2011</year>) <article-title>Prophylaxis for endophthalmitis following intravitreal injection: antisepsis and antibiotics</article-title>. <source>Am J Ophthalmol</source><volume>152</volume>: <fpage>717</fpage>–<lpage>719</lpage> e712. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ajo.2011.07.002">10.1016/j.ajo.2011.07.002</ext-link></comment><pub-id pub-id-type="pmid">22017840</pub-id></mixed-citation></ref><ref id="pone.0156431.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>de Caro</surname><given-names>JJ</given-names></name>, <name><surname>Ta</surname><given-names>CN</given-names></name>, <name><surname>Ho</surname><given-names>HK</given-names></name>, <name><surname>Cabael</surname><given-names>L</given-names></name>, <name><surname>Hu</surname><given-names>N</given-names></name>, <name><surname>Sanislo</surname><given-names>SR</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections</article-title>. <source>Retina</source><volume>28</volume>: <fpage>877</fpage>–<lpage>883</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/IAE.0b013e31816b3180">10.1097/IAE.0b013e31816b3180</ext-link></comment><pub-id pub-id-type="pmid">18536606</pub-id></mixed-citation></ref><ref id="pone.0156431.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Dossarps</surname><given-names>D</given-names></name>, <name><surname>Bron</surname><given-names>AM</given-names></name>, <name><surname>Koehrer</surname><given-names>P</given-names></name>, <name><surname>Aho-Glele</surname><given-names>LS</given-names></name>, <name><surname>Creuzot-Garcher</surname><given-names>C</given-names></name>, <name><surname>FRCR</surname><given-names>Net</given-names></name> (<year>2015</year>) <article-title>Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome</article-title>. <source>Am J Ophthalmol</source><volume>160</volume>: <fpage>17</fpage>–<lpage>25</lpage> e11. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ajo.2015.04.013">10.1016/j.ajo.2015.04.013</ext-link></comment><pub-id pub-id-type="pmid">25892127</pub-id></mixed-citation></ref><ref id="pone.0156431.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Sigford</surname><given-names>DK</given-names></name>, <name><surname>Reddy</surname><given-names>S</given-names></name>, <name><surname>Mollineaux</surname><given-names>C</given-names></name>, <name><surname>Schaal</surname><given-names>S</given-names></name> (<year>2015</year>) <article-title>Global reported endophthalmitis risk following intravitreal injections of anti-VEGF: a literature review and analysis</article-title>. <source>Clin Ophthalmol</source><volume>9</volume>: <fpage>773</fpage>–<lpage>781</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2147/OPTH.S77067">10.2147/OPTH.S77067</ext-link></comment><pub-id pub-id-type="pmid">25999685</pub-id></mixed-citation></ref><ref id="pone.0156431.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>McCannel</surname><given-names>CA</given-names></name> (<year>2011</year>) <article-title>Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies</article-title>. <source>Retina</source><volume>31</volume>: <fpage>654</fpage>–<lpage>661</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/IAE.0b013e31820a67e4">10.1097/IAE.0b013e31820a67e4</ext-link></comment><pub-id pub-id-type="pmid">21330939</pub-id></mixed-citation></ref><ref id="pone.0156431.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Fileta</surname><given-names>JB</given-names></name>, <name><surname>Scott</surname><given-names>IU</given-names></name>, <name><surname>Flynn</surname><given-names>HW</given-names><suffix>Jr</suffix></name> (<year>2014</year>) <article-title>Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents</article-title>. <source>Ophthalmic Surg Lasers Imaging Retina</source><volume>45</volume>: <fpage>143</fpage>–<lpage>149</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3928/23258160-20140306-08">10.3928/23258160-20140306-08</ext-link></comment><pub-id pub-id-type="pmid">24635156</pub-id></mixed-citation></ref><ref id="pone.0156431.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Moshfeghi</surname><given-names>AA</given-names></name>, <name><surname>Rosenfeld</surname><given-names>PJ</given-names></name>, <name><surname>Flynn</surname><given-names>HW</given-names><suffix>Jr</suffix></name>, <name><surname>Schwartz</surname><given-names>SG</given-names></name>, <name><surname>Davis</surname><given-names>JL</given-names></name>, <name><surname>Murray</surname><given-names>TG</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center</article-title>. <source>Retina</source><volume>31</volume>: <fpage>662</fpage>–<lpage>668</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/IAE.0b013e31821067c4">10.1097/IAE.0b013e31821067c4</ext-link></comment><pub-id pub-id-type="pmid">21836400</pub-id></mixed-citation></ref><ref id="pone.0156431.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Bhavsar</surname><given-names>AR</given-names></name>, <name><surname>Googe</surname><given-names>JM</given-names><suffix>Jr</suffix></name>, <name><surname>Stockdale</surname><given-names>CR</given-names></name>, <name><surname>Bressler</surname><given-names>NM</given-names></name>, <name><surname>Brucker</surname><given-names>AJ</given-names></name>, <name><surname>Elman</surname><given-names>MJ</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials</article-title>. <source>Arch Ophthalmol</source><volume>127</volume>: <fpage>1581</fpage>–<lpage>1583</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/archophthalmol.2009.304">10.1001/archophthalmol.2009.304</ext-link></comment><pub-id pub-id-type="pmid">20008710</pub-id></mixed-citation></ref><ref id="pone.0156431.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Cochereau</surname><given-names>I</given-names></name>, <name><surname>Korobelnik</surname><given-names>JF</given-names></name>, <name><surname>Bodaghi</surname><given-names>B</given-names></name> (<year>2013</year>) <article-title>Prevention of post intravitreal injection endophthalmitis: is antibioprophylaxis indicated?</article-title>. <source>J Fr Ophtalmol</source><volume>36</volume>: <fpage>72</fpage>–<lpage>75</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jfo.2012.10.001">10.1016/j.jfo.2012.10.001</ext-link></comment><pub-id pub-id-type="pmid">23245997</pub-id></mixed-citation></ref><ref id="pone.0156431.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Yin</surname><given-names>VT</given-names></name>, <name><surname>Weisbrod</surname><given-names>DJ</given-names></name>, <name><surname>Eng</surname><given-names>KT</given-names></name>, <name><surname>Schwartz</surname><given-names>C</given-names></name>, <name><surname>Kohly</surname><given-names>R</given-names></name>, <name><surname>Mandelcorn</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection</article-title>. <source>JAMA Ophthalmol</source><volume>131</volume>: <fpage>456</fpage>–<lpage>461</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/jamaophthalmol.2013.2379">10.1001/jamaophthalmol.2013.2379</ext-link></comment><pub-id pub-id-type="pmid">23430175</pub-id></mixed-citation></ref><ref id="pone.0156431.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>SJ</given-names></name>, <name><surname>Toma</surname><given-names>HS</given-names></name>, <name><surname>Midha</surname><given-names>NK</given-names></name>, <name><surname>Cherney</surname><given-names>EF</given-names></name>, <name><surname>Recchia</surname><given-names>FM</given-names></name>, <name><surname>Doherty</surname><given-names>TJ</given-names></name> (<year>2010</year>) <article-title>Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections</article-title>. <source>Ophthalmology</source><volume>117</volume>: <fpage>2372</fpage>–<lpage>2378</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ophtha.2010.03.034">10.1016/j.ophtha.2010.03.034</ext-link></comment><pub-id pub-id-type="pmid">20656351</pub-id></mixed-citation></ref><ref id="pone.0156431.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Cheung</surname><given-names>CS</given-names></name>, <name><surname>Wong</surname><given-names>AW</given-names></name>, <name><surname>Lui</surname><given-names>A</given-names></name>, <name><surname>Kertes</surname><given-names>PJ</given-names></name>, <name><surname>Devenyi</surname><given-names>RG</given-names></name>, <name><surname>Lam</surname><given-names>WC</given-names></name> (<year>2012</year>) <article-title>Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections</article-title>. <source>Ophthalmology</source><volume>119</volume>: <fpage>1609</fpage>–<lpage>1614</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ophtha.2012.02.014">10.1016/j.ophtha.2012.02.014</ext-link></comment><pub-id pub-id-type="pmid">22480743</pub-id></mixed-citation></ref><ref id="pone.0156431.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>da Costa</surname><given-names>BR</given-names></name>, <name><surname>Cevallos</surname><given-names>M</given-names></name>, <name><surname>Altman</surname><given-names>DG</given-names></name>, <name><surname>Rutjes</surname><given-names>AW</given-names></name>, <name><surname>Egger</surname><given-names>M</given-names></name> (<year>2011</year>) <article-title>Uses and misuses of the STROBE statement: bibliographic study</article-title>. <source>BMJ Open</source><volume>1</volume>: <fpage>e000048</fpage><comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bmjopen-2010-000048">10.1136/bmjopen-2010-000048</ext-link></comment><pub-id pub-id-type="pmid">22021739</pub-id></mixed-citation></ref><ref id="pone.0156431.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Vandenbroucke</surname><given-names>JP</given-names></name>, <name><surname>von Elm</surname><given-names>E</given-names></name>, <name><surname>Altman</surname><given-names>DG</given-names></name>, <name><surname>Gotzsche</surname><given-names>PC</given-names></name>, <name><surname>Mulrow</surname><given-names>CD</given-names></name>, <name><surname>Pocock</surname><given-names>SJ</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration</article-title>. <source>Annals of Internal Medicine</source><volume>147</volume>: <fpage>W163</fpage>–<lpage>194</lpage>. <pub-id pub-id-type="pmid">17938389</pub-id></mixed-citation></ref><ref id="pone.0156431.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Bhatt</surname><given-names>SS</given-names></name>, <name><surname>Stepien</surname><given-names>KE</given-names></name>, <name><surname>Joshi</surname><given-names>K</given-names></name> (<year>2011</year>) <article-title>Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate</article-title>. <source>Retina</source><volume>31</volume>: <fpage>2032</fpage>–<lpage>2036</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/IAE.0b013e31820f4b4f">10.1097/IAE.0b013e31820f4b4f</ext-link></comment><pub-id pub-id-type="pmid">21659941</pub-id></mixed-citation></ref><ref id="pone.0156431.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Meredith</surname><given-names>TA</given-names></name>, <name><surname>McCannel</surname><given-names>CA</given-names></name>, <name><surname>Barr</surname><given-names>C</given-names></name>, <name><surname>Doft</surname><given-names>BH</given-names></name>, <name><surname>Peskin</surname><given-names>E</given-names></name>, <name><surname>Maguire</surname><given-names>MG</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Postinjection endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT)</article-title>. <source>Ophthalmology</source><volume>122</volume>: <fpage>817</fpage>–<lpage>821</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ophtha.2014.10.027">10.1016/j.ophtha.2014.10.027</ext-link></comment><pub-id pub-id-type="pmid">25600198</pub-id></mixed-citation></ref><ref id="pone.0156431.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Pachuo</surname><given-names>M</given-names></name>, <name><surname>Sahto</surname><given-names>A</given-names></name>, <name><surname>Quraishi</surname><given-names>M</given-names></name>, <name><surname>Abbasi</surname><given-names>A</given-names></name> (<year>2015</year>) <article-title>Role of Post-injection Antibiotics after Intravitreal Bevacizumab Injection in Preventing Endophthalmitis</article-title>. <source>Pak J Ophtalmol</source> Vol <volume>31</volume>.</mixed-citation></ref><ref id="pone.0156431.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Storey</surname><given-names>P</given-names></name>, <name><surname>Dollin</surname><given-names>M</given-names></name>, <name><surname>Pitcher</surname><given-names>J</given-names></name>, <name><surname>Reddy</surname><given-names>S</given-names></name>, <name><surname>Vojtko</surname><given-names>J</given-names></name>, <name><surname>Vander</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection</article-title>. <source>Ophthalmology</source><volume>121</volume>: <fpage>283</fpage>–<lpage>289</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ophtha.2013.08.037">10.1016/j.ophtha.2013.08.037</ext-link></comment><pub-id pub-id-type="pmid">24144453</pub-id></mixed-citation></ref><ref id="pone.0156431.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Ramel</surname><given-names>JC</given-names></name>, <name><surname>Bron</surname><given-names>AM</given-names></name>, <name><surname>Isaico</surname><given-names>R</given-names></name>, <name><surname>Meillon</surname><given-names>C</given-names></name>, <name><surname>Binquet</surname><given-names>C</given-names></name>, <name><surname>Creuzot-Garcher</surname><given-names>C</given-names></name> (<year>2014</year>) <article-title>Incidence of endophthalmitis after intravitreal injection: is antibioprophylaxis mandatory?</article-title>. <source>J Fr Ophtalmol</source><volume>37</volume>: <fpage>273</fpage>–<lpage>279</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jfo.2014.01.003">10.1016/j.jfo.2014.01.003</ext-link></comment><pub-id pub-id-type="pmid">24655790</pub-id></mixed-citation></ref><ref id="pone.0156431.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Bhavsar</surname><given-names>AR</given-names></name>, <name><surname>Stockdale</surname><given-names>CR</given-names></name>, <name><surname>Ferris</surname><given-names>FL</given-names><suffix>III</suffix></name>, <name><surname>Brucker</surname><given-names>AJ</given-names></name>, <name><surname>Bressler</surname><given-names>NM</given-names></name>, <name><surname>Glassman</surname><given-names>AR</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics</article-title>. <source>Arch Ophthalmol</source><volume>130</volume>: <fpage>809</fpage>–<lpage>810</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/archophthalmol.2012.227">10.1001/archophthalmol.2012.227</ext-link></comment><pub-id pub-id-type="pmid">22801859</pub-id></mixed-citation></ref><ref id="pone.0156431.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>Y</given-names></name>, <name><surname>Kim</surname><given-names>KS</given-names></name>, <name><surname>Park</surname><given-names>YH</given-names></name> (<year>2013</year>) <article-title>Acute endophthalmitis after intravitreal injection and preventive effect of preoperative topical antibiotics</article-title>. <source>J Ocul Pharmacol Ther</source><volume>29</volume>: <fpage>900</fpage>–<lpage>905</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/jop.2013.0052">10.1089/jop.2013.0052</ext-link></comment><pub-id pub-id-type="pmid">24067061</pub-id></mixed-citation></ref><ref id="pone.0156431.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Stranak</surname><given-names>Z</given-names></name>, <name><surname>Veith</surname><given-names>M</given-names></name>, <name><surname>Studeny</surname><given-names>P</given-names></name>, <name><surname>Pencak</surname><given-names>M</given-names></name> (<year>2014</year>) <article-title>The incidence of endophtalmitis after the application of intravitreal injections in FNKV with regard to various prophylactic antibiotic regimens</article-title>. <source>Cesk Slov Oftalmol</source><volume>70</volume>: <fpage>184</fpage>–<lpage>188</lpage>. <pub-id pub-id-type="pmid">25640041</pub-id></mixed-citation></ref><ref id="pone.0156431.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Mino De Kaspar</surname><given-names>H</given-names></name>, <name><surname>Hoepfner</surname><given-names>AS</given-names></name>, <name><surname>Engelbert</surname><given-names>M</given-names></name>, <name><surname>Thiel</surname><given-names>M</given-names></name>, <name><surname>Ta</surname><given-names>CN</given-names></name>, <name><surname>Mette</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>Antibiotic resistance pattern and visual outcome in experimentally-induced Staphylococcus epidermidis endophthalmitis in a rabbit model</article-title>. <source>Ophthalmology</source><volume>108</volume>: <fpage>470</fpage>–<lpage>478</lpage>. <pub-id pub-id-type="pmid">11237900</pub-id></mixed-citation></ref><ref id="pone.0156431.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Moss</surname><given-names>JM</given-names></name>, <name><surname>Sanislo</surname><given-names>SR</given-names></name>, <name><surname>Ta</surname><given-names>CN</given-names></name> (<year>2009</year>) <article-title>A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections</article-title>. <source>Ophthalmology</source><volume>116</volume>: <fpage>1498</fpage>–<lpage>1501</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ophtha.2009.02.024">10.1016/j.ophtha.2009.02.024</ext-link></comment><pub-id pub-id-type="pmid">19501409</pub-id></mixed-citation></ref><ref id="pone.0156431.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Isenberg</surname><given-names>SJ</given-names></name>, <name><surname>Apt</surname><given-names>L</given-names></name>, <name><surname>Yoshimori</surname><given-names>R</given-names></name>, <name><surname>Khwarg</surname><given-names>S</given-names></name> (<year>1985</year>) <article-title>Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic</article-title>. <source>Arch Ophthalmol</source><volume>103</volume>: <fpage>1340</fpage>–<lpage>1342</lpage>. <pub-id pub-id-type="pmid">2994609</pub-id></mixed-citation></ref><ref id="pone.0156431.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>SJ</given-names></name>, <name><surname>Toma</surname><given-names>HS</given-names></name> (<year>2011</year>) <article-title>Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections</article-title>. <source>Ophthalmology</source><volume>118</volume>: <fpage>1358</fpage>–<lpage>1363</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ophtha.2010.12.014">10.1016/j.ophtha.2010.12.014</ext-link></comment><pub-id pub-id-type="pmid">21420176</pub-id></mixed-citation></ref><ref id="pone.0156431.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Costello</surname><given-names>P</given-names></name>, <name><surname>Bakri</surname><given-names>SJ</given-names></name>, <name><surname>Beer</surname><given-names>PM</given-names></name>, <name><surname>Singh</surname><given-names>RJ</given-names></name>, <name><surname>Falk</surname><given-names>NS</given-names></name>, <name><surname>Peters</surname><given-names>GB</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Vitreous penetration of topical moxifloxacin and gatifloxacin in humans</article-title>. <source>Retina</source><volume>26</volume>: <fpage>191</fpage>–<lpage>195</lpage>. <pub-id pub-id-type="pmid">16467677</pub-id></mixed-citation></ref><ref id="pone.0156431.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Bodaghi</surname><given-names>B</given-names></name>, <name><surname>Korobelnik</surname><given-names>JF</given-names></name>, <name><surname>Cochereau</surname><given-names>I</given-names></name>, <name><surname>Hajjar</surname><given-names>J</given-names></name>, <name><surname>Goebel</surname><given-names>F</given-names></name>, <name><surname>Dumarcet</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Intravitreal injections: AFSSAPS guide to good practice</article-title>. <source>J Fr Ophtalmol</source><volume>35</volume>: <fpage>69</fpage>–<lpage>71</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jfo.2011.11.005">10.1016/j.jfo.2011.11.005</ext-link></comment><pub-id pub-id-type="pmid">22226388</pub-id></mixed-citation></ref><ref id="pone.0156431.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Bhavsar</surname><given-names>AR</given-names></name>, <name><surname>Sandler</surname><given-names>DR</given-names></name> (<year>2015</year>) <article-title>Eliminating antibiotic prophylaxis for intravitreal injections: a consecutive series of 18,839 injections by a single surgeon</article-title>. <source>Retina</source><volume>35</volume>: <fpage>783</fpage>–<lpage>788</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/IAE.0000000000000392">10.1097/IAE.0000000000000392</ext-link></comment><pub-id pub-id-type="pmid">25526099</pub-id></mixed-citation></ref><ref id="pone.0156431.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>LeLorier</surname><given-names>J</given-names></name>, <name><surname>Gregoire</surname><given-names>G</given-names></name>, <name><surname>Benhaddad</surname><given-names>A</given-names></name>, <name><surname>Lapierre</surname><given-names>J</given-names></name>, <name><surname>Derderian</surname><given-names>F</given-names></name> (<year>1997</year>) <article-title>Discrepancies between meta-analyses and subsequent large randomized, controlled trials</article-title>. <source>New England Journal of Medicine</source><volume>337</volume>: <fpage>536</fpage>–<lpage>542</lpage>. <pub-id pub-id-type="pmid">9262498</pub-id></mixed-citation></ref></ref-list></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000615 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000615 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:4892688
|texte= Antibioprophylaxis in Prevention of Endophthalmitis in Intravitreal Injection: A Systematic Review and Meta-Analysis
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:27257676" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |